Zhenhua Wu PhD

Dr. Zhenhua Wu is the Founder, Chairman, and Chief Executive Officer of Exegenesis Bio. Dr. Wu is a senior discovery and development leader with more than 20 years of experience and a deep understanding of the pharmaceutical R&D value chain. He has extensive R&D experience in small-molecule, vaccine, and cell- and gene-therapy. Dr. Wu was the CEO of NeuExcell Therapeutics, overseeing all corporate operations and business activities. Previously, he was the Vice President and Head of Preclinical Development at United Neuroscience, overseeing the strategy and execution of preclinical research and development.

He served as a director of the neuroscience therapeutic area at GlaxoSmithKline, where he led cell and gene therapy and small molecule projects for the treatment of neurodegenerative and neuroinflammatory diseases. He had worked in various functional areas in Merck & Co. for ten years, where he led various neuroscience projects. Dr. Wu received his Ph.D. degree in neuroscience from the University of Rochester.